Idioma:

Gastric cancer: Current status of lymph node dissection

Degiuli, Maurizio ; De Manzoni, Giovanni ; Di Leo, Alberto ; D'Ugo, Domenico ; Galasso, Erica ; Marrelli, Daniele ; Petrioli, Roberto ; Polom, Karol ; Roviello, Franco ; Santullo, Francesco ; Morino, Mario

World journal of gastroenterology : WJG, 2016-03, Vol.22 (10), p.2875-2893

United States: Baishideng Publishing Group Inc

Texto completo disponível

Citações Citado por

Enviar para

Título:
Gastric cancer: Current status of lymph node dissection
Autor: Degiuli, Maurizio ; De Manzoni, Giovanni ; Di Leo, Alberto ; D'Ugo, Domenico ; Galasso, Erica ; Marrelli, Daniele ; Petrioli, Roberto ; Polom, Karol ; Roviello, Franco ; Santullo, Francesco ; Morino, Mario
Assuntos: cancer; Lymph ; dissection; Lymphadenectomy; D2 ; Early Detection of Cancer ; gastrecto ; Gastrectomy - adverse effects ; Gastrectomy - methods ; Gastrectomy - mortality ; gastrectomy; D1 ; Gastric ; Gastroscopy - adverse effects ; Gastroscopy - mortality ; Humans ; Laparoscopy ; Lymph Node Excision - adverse effects ; Lymph Node Excision - methods ; Lymph Node Excision - mortality ; Lymph Nodes - pathology ; Lymph Nodes - surgery ; Lymphatic Metastasis ; Neoplasm Staging ; node ; Pancreatectomy ; plus ; Risk Factors ; Robotic Surgical Procedures ; Splenectomy ; Stomach Neoplasms - mortality ; Stomach Neoplasms - pathology ; Stomach Neoplasms - surgery ; Survival Analysis ; Topic Highlight ; Treatment Outcome
É parte de: World journal of gastroenterology : WJG, 2016-03, Vol.22 (10), p.2875-2893
Notas: Maurizio Degiuli;Giovanni De Manzoni;Alberto Di Leo;Domenico D’Ugo;Erica Galasso;Daniele Marrelli;Roberto Petrioli;Karol Polom;Franco Roviello;Francesco Santullo;Mario Morino;Department of Surgery,University of Turin,Citta della Salute e della Scienza;Department of Surgery,University of Verona,Ospedale Borgo Trento;Division of Surgery,Ospedale di Arco;Department of Surgery,University "Cattolica del Sacro Cuore","A.Gemelli" University Hospital;Department of Surgery,University of Siena;Department of Oncology,University of Siena;Department of Surgery,Wielkopolskie Centrum Onkologii
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Telephone: +39-335-8111286 Fax: +39-11-6336725
Correspondence to: Maurizio Degiuli, MD, Chirurgia Generale Universitaria 1, Department of Surgery, University of Turin, Citta della salute e della scienza, 10126 Turin, Italy. dr.mauriziodegiuli@gmail.com
Author contributions: Degiuli M designed the article structure; Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Roviello F, Santullo F and Morino M. contributed equally to this work and wrote the paper.
Descrição: D2 procedure has been accepted in Far East as the standard treatment for both early(EGC) and advanced gastric cancer(AGC) for many decades. Recently EGC has been successfully treated with endoscopy by endoscopic mucosal resection or endoscopic submucosal dissection, when restricted or extended Gotoda’s criteria can be applied and D1+ surgery is offered only to patients not fitted for less invasive treatment. Furthermore, two randomised controlled trials(RCTs) have been demonstrating the non inferiority of minimally invasive technique as compared to standard open surgery for the treatment of early cases and recently the feasibility of adequate D1+ dissection has been demonstrated also for the robot assisted technique. In case of AGC the debate on the extent of nodal dissection has been open for many decades. While D2 gastrectomy was performed as the standard procedure in eastern countries, mostly based on observational and retrospective studies, in the west the Medical Research Council(MRC), Dutch and Italian RCTs have been conducted to show a survival benefit of D2 over D1 with evidence based medicine. Unfortunately both the MRC and the Dutch trials failed to show a survival benefit after the D2 procedure, mostly due to the significant increase of postoperative morbidity and mortality, which was referred to splenopancreatectomy. Only 15 years after the conclusion of its accrual, the Dutch trial could report a significant decrease of recur-rence after D2 procedure. Recently the long term survival analysis of the Italian RCT could demonstrate a benefit for patients with positive nodes treated with D2 gastrectomy without splenopancreatectomy. As nowadays also in western countries D2 procedure can be done safely with pancreas preserving technique and without preventive splenectomy, it has been suggested in several national guidelines as the recommended procedure for patients with AGC.
Editor: United States: Baishideng Publishing Group Inc
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Gastric cancer: Current status of lymph node dissection

Degiuli, Maurizio ; De Manzoni, Giovanni ; Di Leo, Alberto ; D'Ugo, Domenico ; Galasso, Erica ; Marrelli, Daniele ; Petrioli, Roberto ; Polom, Karol ; Roviello, Franco ; Santullo, Francesco ; Morino, Mario

United States: Baishideng Publishing Group Inc

Buscando em bases de dados remotas. Favor aguardar.